Metabolic syndrome in HIV-infected patients from an urban, midwestern US outpatient population. - Wikidata - awgldk - TriplyDB

Metabolic syndrome in HIV-infected patients from an urban, midwestern US outpatient population.

Metabolic syndrome in HIV-infected patients from an urban, midwestern US outpatient population.

http://www.wikidata.org/entity/Q35206670

about

Pharmacological interventions for treating dyslipidemia in patients with HIV infection Influence of immune activation and inflammatory response on cardiovascular risk associated with the human immunodeficiency virus Metabolic syndrome, diabetes, and cardiovascular risk in HIV Presence of the metabolic syndrome is not a better predictor of cardiovascular disease than the sum of its components in HIV-infected individuals: data collection on adverse events of anti-HIV drugs (D:A:D) study.Diabetes mellitus, preexisting coronary heart disease, and the risk of subsequent coronary heart disease events in patients infected with human immunodeficiency virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D Study).Monocyte bioenergetic function is associated with body composition in virologically suppressed HIV-infected women Impact of Lipodystrophy on the prevalence and components of metabolic syndrome in HIV-infected patients.Prevalence of metabolic syndrome in human immunodeficiency virus - infected patients from the South-West region of Cameroon, using the adult treatment panel III criteria.Approach to dyslipidemia, lipodystrophy, and cardiovascular risk in patients with HIV infection.Lipid profile in HIV/AIDS patients in Nigeria Effects of PPARγ and RBP4 gene variants on metabolic syndrome in HIV-infected patients with anti-retroviral therapy Understanding diabetes in patients with HIV/AIDS Relationship of ethnicity and CD4 Count with glucose metabolism among HIV patients on Highly-Active Antiretroviral Therapy (HAART)Prevalence of cardiometabolic risk factors in Hispanics living with HIV.Metabolic abnormalities and coronary heart disease risk in human immunodeficiency virus-infected adults.HIV and HAART-Associated Dyslipidemia HIV and general cardiovascular risk.A cross-sectional assessment of metabolic syndrome in HIV-infected people of low socio-economic status receiving antiretroviral therapy Hypertriglyceridemia, Metabolic Syndrome, and Cardiovascular Disease in HIV-Infected Patients: Effects of Antiretroviral Therapy and Adipose Tissue Distribution.HIV therapy, metabolic syndrome, and cardiovascular risk.Adverse host factors exacerbate occult HIV-associated nephropathy.South Asian Consensus Guidelines for the rational management of diabetes in human immunodeficiency virus/acquired immunodeficiency syndrome.Effects of human immunodeficiency virus and metabolic complications on myocardial nutrient metabolism, blood flow, and oxygen consumption: a cross-sectional analysis.Correlation between HIV disease and lipid metabolism in antiretroviral-naïve HIV-infected patients in Japan.Highly active antiretroviral therapy and dyslipidemia in people living with HIV/AIDS in Fako Division, South West Region of Cameroon Maternal post-absorptive leucine kinetics during late pregnancy in US women with HIV taking antiretroviral therapy: a cross-sectional pilot study.Influences of gender in metabolic syndrome and its components among people living with HIV virus using antiretroviral treatment in Hawassa, southern Ethiopia.A Meta-Analysis of the Metabolic Syndrome Prevalence in the Global HIV-Infected Population.Dysregulation of glucose metabolism in HIV patients: epidemiology, mechanisms, and management.Risk Factors of Cardiovascular Diseases in HIV/AIDS Patients on HAART.Metabolic syndrome before and after initiation of antiretroviral therapy in treatment-naive HIV-infected individuals Comparison of Adenosine Deaminase, Zinc, Magnesium, Lipid Profile, and some Micronutrient Elements and their Relation with CD4 Counts in Human Immunodeficiency Virus Positive and Negative Patients Metabolic syndrome predicts all-cause mortality in persons with human immunodeficiency virus Metabolic syndrome in human immunodeficiency virus positive patients.Prevalence of metabolic syndrome among HIV-infected patients in Ghana: A cross-sectional study.Relationships among HIV infection, metabolic risk factors, and left ventricular structure and function Development of appropriate coronary heart disease risk prediction models in HIV-infected patients.Increased burden and severity of metabolic syndrome and arterial stiffness in treatment-naïve HIV+ patients from Cameroon.Human immunodeficiency virus downregulates podocyte apoE expression.Metabolic syndrome in HIV-infected individuals: underlying mechanisms and epidemiological aspects.

P2860

Q24236121-8A2FD1B0-7B16-41A3-AEA4-152C487F1500 Q26851535-2A8A710A-4004-4D56-9604-4B8552340595 Q26853470-A249AC56-38DD-425C-B260-DA6938A08EC4 Q33389734-439A7521-44E9-4F80-872E-C38212420716 Q33404972-8059EBEB-F6AF-4BCD-AE1F-C81C4FE45179 Q33555718-7DE8853F-6AA1-4524-9145-C597E882E3BA Q34024617-AFF30167-82A8-4D85-AADA-CD95192B1AF0 Q34136175-9B07B6F9-DA78-48AC-8D7F-9030136E722A Q34156361-00A54BF9-6950-4EFD-AACD-413D3F902110 Q34206446-1F3698F1-89B0-4972-AE20-C3AC47F0C59A Q34474050-3F87B0E2-9AB1-4E50-922F-CB8A84484F64 Q34515251-3A6EDDAC-9FA1-4868-B56C-5F90FC687E9C Q34680474-3450CCF1-3A2E-48D6-929A-ED2CEE8F952C Q34766026-6540D9D0-09F3-4995-A5F4-5E6D976DE5C8 Q34896246-2FEB39A6-EF75-4F24-A8D6-3F01BE0E5DC9 Q35020217-41990AFC-FF32-4D2A-8286-476E4DB0D239 Q35118909-5B0FA3D0-4D79-439B-92EC-93419E28618C Q35166766-FCB392F7-2195-4FF1-BF3E-143D5EB79517 Q35176441-B24E3D62-472A-4357-8AED-15BDF3E697BC Q35194399-0F6B338B-02B8-476B-9B07-B831312CEB8C Q35235846-4B2CBC41-1EE9-42CA-963F-F0B1C504E94E Q35352433-FDFC0F7B-5F71-4B32-97BC-D2F058FED2AA Q35672526-21D47F87-111E-47DB-8A58-1465E65AD8ED Q35754336-7B8A48F3-9213-4FB1-861A-97C01DEBE881 Q35758159-EE1EC189-9813-447F-834F-AED6DDABC613 Q35927192-5A5C2C52-1C09-4A39-B4FD-F02F6495BD7A Q35946656-308EF042-F7A6-4FD7-9D7A-E2E9CCDC30F1 Q35967926-CDD17F2E-D3E4-4113-B95F-154D6BEE68A0 Q36158019-6D7BF766-8835-4578-943F-47C365249ED2 Q36282430-22709726-3244-47B0-B33D-31E14E38CB73 Q36346699-F27945E6-E392-4484-904B-08274D51D1D2 Q36527681-F3077B1E-0605-49C9-9228-746618FF1130 Q36836525-F2F664F4-8451-4CB8-A104-C38880F8B175 Q36862157-7C716F3E-88E4-49AE-87C6-84A1E2136B13 Q36915645-4909C350-3824-4F5D-9CC5-28D0B5ABDE7F Q37025613-0552A5AB-673B-4D19-B863-8F185D995620 Q37111718-1F477A92-2E22-4A96-B6F1-50BC23007B3D Q37169956-36B557A9-4CC6-40AD-A410-90EF7D0F484B Q37337364-6235BE0D-6648-4F5A-95A1-C112F6E95614 Q37418053-7FDB1078-47CA-4BA0-9C44-D7972B93C8DA

P2860

Metabolic syndrome in HIV-infected patients from an urban, midwestern US outpatient population.

http://www.wikidata.org/entity/Q35206670

description

2007 nî lūn-bûn

@nan

2007 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Metabolic syndrome in HIV-infe ...... tern US outpatient population.

@ast

Metabolic syndrome in HIV-infe ...... tern US outpatient population.

@en

type

label

Metabolic syndrome in HIV-infe ...... tern US outpatient population.

@ast

Metabolic syndrome in HIV-infe ...... tern US outpatient population.

@en

prefLabel

Metabolic syndrome in HIV-infe ...... tern US outpatient population.

@ast

Metabolic syndrome in HIV-infe ...... tern US outpatient population.

@en

P1433

Q35206670-79CCA6FC-B09B-4A1D-AA1B-758B7AA5C1CB

P1476

Q35206670-AE5C5FF1-725C-41CA-A03C-BEE3A7398208

P2093

Q35206670-01D88678-1BC5-42B5-9482-686925CFE2CD

Q35206670-21D77308-3861-4CCE-B811-65AE5DDB8EE4

Q35206670-6643F1DC-7CEE-4163-B724-8F655A29B046

Q35206670-9E64E1FD-5DB0-4E15-93F7-76E0F976C950

Q35206670-DAC0E42D-4AE7-49E7-951D-627F30B69E1F

Q35206670-FF0F5A96-645C-40FD-9071-D4AB9B0CCC24

P2860

Q35206670-076C57DC-F4E0-4605-BBF5-6CE19CBE33AE

Q35206670-0C374037-98D9-45C9-804F-D6EF97F0D013

Q35206670-129F92AC-D07C-4C6B-93D4-90EB210476FD

Q35206670-19257612-8D60-45B3-BF98-E9A82C0A6791

Q35206670-25A4DF92-69F3-4371-83D4-6930734F243A

Q35206670-27837CAF-F40B-45DE-8BDD-8284ED0D460F

Q35206670-27E2F834-3C34-4F2F-8BF8-6CE99651BDED

Q35206670-32E2190B-0568-434A-9820-34FE1DA12FEE

Q35206670-3E19C5BE-EB63-4612-83DE-BE7F57885EDA

Q35206670-4113B0A0-B325-4A2D-9407-1A131652BB33

P304

Q35206670-C8670E3B-5B29-456C-9B40-387038F5773D

P31

Q35206670-35FBAA0A-0E47-42E8-9822-67C75A35D154

P356

Q35206670-E80F3E34-9CE1-40E0-9549-D0F20243A53A

P407

Q35206670-3AEDEB08-E854-421D-99D4-BA0B7034DF11

P433

Q35206670-03DACC84-AE81-419F-A461-E14EA0126657

P478

Q35206670-F12BD186-45DC-4AE3-89ED-E6A5B1290FA6

P50

Q35206670-2120C981-D271-42B3-BD76-2877DCFC5EF3

P577

Q35206670-F37084F8-4760-4415-9F63-8FECB6CAF362

P5875

Q35206670-7CE30874-FA1B-436F-B00C-46D06CFBA912

P698

Q35206670-BF748C34-C855-4214-99E8-9D66A11419A6

P921

Q35206670-687A3836-ED33-403E-B96A-DC9607DB8889

P932

Q35206670-7BD006FD-E9C3-4D2A-8D99-A25962F69CA5

P356

P1433

Clinical Infectious Diseases

P1476

Metabolic syndrome in HIV-infe ...... tern US outpatient population.

@en

P2093

Edgar Turner Overton

http://www.w3.org/2001/XMLSchema#string

Jessica Grubb

http://www.w3.org/2001/XMLSchema#string

Kristin Mondy

http://www.w3.org/2001/XMLSchema#string

Shao Tong

http://www.w3.org/2001/XMLSchema#string

Warren Seyfried

http://www.w3.org/2001/XMLSchema#string

William Powderly

http://www.w3.org/2001/XMLSchema#string

P2860

Prediction of Coronary Heart Disease Using Risk Factor Categories

Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition

Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study.

Insulin resistance in HIV protease inhibitor-associated diabetes.

Cardiovascular risk and body-fat abnormalities in HIV-infected adults.

Cardiovascular morbidity and mortality associated with the metabolic syndrome

P304

726-734

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/511679

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

44

http://www.w3.org/2001/XMLSchema#string

P50

Kevin Yarasheski

P577

2007-01-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6526832

http://www.w3.org/2001/XMLSchema#string

P698

17278068

http://www.w3.org/2001/XMLSchema#string

P921

metabolic syndrome

P932

3170426

http://www.w3.org/2001/XMLSchema#string